期刊文献+

烯丙雌醇联合利托君治疗习惯性流产的疗效观察 被引量:29

Efficacy Observation of Allylestrenol Combined with Ritodrine in Treatment of Habitual Abortion
下载PDF
导出
摘要 目的:探讨烯丙雌醇和利托君联合治疗孕妇习惯性流产的临床疗效。方法:按随机数字表法将144例习惯性流产患者分为对照组和观察组,每组各72例。观察组患者应用利托君联合烯丙雌醇进行治疗,对照组患者应用硫酸镁联合烯丙雌醇进行治疗,观察2组患者的临床治疗效果、保胎成功率和不良反应发生情况。结果:治疗后,观察组患者的总有效率为94.44%(68/72),保胎成功率为77.89%(56/72);对照组患者的总有效率为63.89%(46/72),保胎成功率为55.56%(40/72),2组的差异有统计学意义(P<0.05)。观察组和对照组患者治疗后的黄体酮激素为(190.12±60.97)、(163.21±64.88)mmol/L,人绒毛膜促性腺激素为(7 319.98±1 032.03)、(5 797.01±954.12)U/L,均较治疗前显著升高,且观察组明显高于对照组,差异均有统计学意义(P<0.05)。2组患者在治疗过程中均未出现明显不良反应。结论:烯丙雌醇联合利托君治疗习惯性流产的疗效显著,可提高妊娠的成功率,且无明显不良反应,值得临床推广。 OBJECTIVE: To probe into the clinical efficacy of allylestrenol combined with ritodrine in treatment of habitual abortion. METHODS: 144 patients with habitual abortion were divided into observation group and control group via the random number table,with 72 cases in each group. The observation group were treated with allylestrenol combined with ritodrine,while the control group received magnesium sulfate combined with allylestrenol,the clinical efficacy,rate of pregnancy and adverse reactions were observed in two groups. RESULTS: After treatment,the total effective rate and the rate of pregnancy in observation group and control group were respectively [94. 44%( 68 /72) VS63. 89%( 46 /72),77. 89%( 56 /72) VS 55. 56%( 40 /72) ],the difference was statistically significant( P〈0. 05);and the progesterone hormone were respectively( 190. 12 ± 60. 97) mmol / L and( 163. 21 ± 64. 88) mmol / L,human chorionic gonadotrophin were respectively( 7 319. 98 ± 1 032. 03) U / L and( 5 797. 01 ± 954. 12) U / L,both of which were significantly improved than before treatment,with statistically significant difference( P〈0. 05). There were no obvious adverse reactions between two groups during the treatment. CONCLUSIONS: The efficacy of allylestrenol combined with ritodrine in treatment of habitual abortion is significant,which can improve the rate of pregnancy with no obvious adverse reactions. It is worthy of clinical promotion.
作者 袁金兰 杨岚
出处 《中国医院用药评价与分析》 2015年第12期1580-1582,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 利托君 烯丙雌醇 习惯性流产 Ritodrine Allylestrenol Habitual abortion
  • 相关文献

参考文献16

二级参考文献36

  • 1李敏,焦见芬.烯丙雌醇与戊酸雌二醇对反复流产患者子宫内膜雌孕激素受体的作用观察[J].山东医药,2007,47(18):69-70. 被引量:7
  • 2傅秋仙,楼红英.烯丙雌醇应用于不同时期复发性自然流产的临床研究[J].中国妇幼保健,2004,19(8):104-105. 被引量:2
  • 3张歌平,李伯群,张仲慧.固胎煎治疗胎漏、胎动不安32例[J].中医研究,1995,8(4):47-49. 被引量:1
  • 4龙凤宜,范江涛,李建华.血清孕酮、IL-8、TNF-α在先兆流产中的意义[J].实用妇产科杂志,2006,22(2):92-94. 被引量:38
  • 5Ingemarsson I, Lamont RF. An update on the controversies of tocolytic therapy for the prevention of pretenn birth. Acta Obstet Gynecol Seand, 2003, 82 : 1-9.
  • 6The Worldwide Atosiban versus Beta-agonists Study Group.Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenerglc agonists in the treatment of preterm labour. Br J Obstet Gynanecol, 2001, 108: 133-142.
  • 7Shim JY, Park YW, Yoon BH, et al. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women. Br J Obstet Gynanecol, 2006, 113 : 1228-1234.
  • 8Tsatsaris V, Carbonne B, Cabrol D. Atosiban for preterm labour. Drugs, 2004, 64: 375-382.
  • 9Di Renzo G, Al Saleh E, Mattei A, et al. Use of tocolytics : what is the benefit of gaining 48 hours for the fetus? Br J Obstet Gynanecol, 2006, 113: 72-77.
  • 10Romero R, Sibai BM, Sanchez-Ramos L, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double, blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol, 2000, 182: 1173-1183.

共引文献116

同被引文献135

引证文献29

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部